Cardiovascular

Laptor

Atorvastatin

INN

Atorvastatin

Dosage form

Film-coated tablets

Therapeutic area

Cardiovascular

Indications

Hypercholesterolaemia: LAPTOR is indicated as an adjunct to diet to reduce elevated total cholesterol (total-C), LDL cholesterol (LDL-C), apolipoprotein B and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, or combined (mixed) hyperlipidaemia (Fredrickson types IIa and IIb), when response to diet and other non-pharmacological measures is inadequate. LAPTOR is also indicated to reduce total-C and LDL-C in adults with homozygous familial hypercholesterolaemia as an adjunct to other lipid-lowering treatments (e.g. LDL apheresis) or if such treatments are unavailable. Prevention of cardiovascular disease: prevention of cardiovascular events in adult patients estimated to have a high risk for a first cardiovascular event, as an adjunct to correction of other risk factors.

Presentations

Presentation	Strength	Pack size
Laptor	10mg	Box of 30
Laptor	20mg	Box of 30
Laptor	40mg	Box of 30
Laptor	80mg	Box of 30

Information intended for healthcare professionals. Prescription-only medicine in accordance with current regulations: read the package leaflet carefully. Translation provided for information only. Only the package leaflet approved in the country of marketing is authoritative.